Home LiteratureArticle Details
PMID: 3981223 Published · ppublish English Journal Article

Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival.

Loeffler JS, Ervin TJ, Mauch P, Skarin A, Weinstein HJ, Canellos G, Cassady JR

Abstract

Primary lymphomas of the CNS are rare tumors accounting for less than 2% of all extranodal non-Hodgkin's lymphomas. The treatment for this disease has been disappointing. Radiation therapy and surgery have produced consistently poor control of this disease, with a median survival of 15 months. We have reviewed ten cases of primary lymphoma of the CNS treated at the Joint Center for Radiation Therapy or Dana-Farber Cancer Institute (Boston) from 1968 to 1981. All patients had biopsy-proven CNS lymphomas without systemic disease at presentation. In our series, control of CNS lymphoma was seen only in patients receiving craniospinal radiation or CNS-penetrating chemotherapy.

MeSH Terms
Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols/therapeutic use Brain Neoplasms/mortality,therapy Child Combined Modality Therapy Dose-Response Relationship, Radiation Female Humans Lymphoma/mortality,therapy Male Middle Aged Neoplasm Metastasis Neoplasm Recurrence, Local Spinal Cord Neoplasms/mortality,therapy
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Loeffler J S
Ervin T J
Mauch P
Skarin A
Weinstein H J
Canellos G
Cassady J R
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
0732-183X
Published
1985-04-00
Pages
490-4
Language
English
Region
United States
NLM ID
8309333
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]